NCT06165809 2023-12-29
A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Withdrawn
Clinical Trials
10 trialsNCT05490381 2023-12-12
Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes
University of Washington
Phase 1 Withdrawn
NCT05650203 2023-04-05
A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Withdrawn
NCT03177681 2023-03-27
The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT04088032 2020-07-16
Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer
Stony Brook University
Phase EARLY_PHASE1 Withdrawn
NCT03128281 2019-05-30
Pneumoperitoneum Management With Low vs. Higher Pressure
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT03207542 2018-07-26
Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL)
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT02812056 2017-03-27
Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT02539615 2016-01-25
A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years Old
Atossa Therapeutics, Inc.
Phase 3 Withdrawn
NCT00027976 2013-08-05
Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses
University of Alabama at Birmingham
Phase 2/3 Withdrawn